Internal Medicine · Lincoln, CA
NPI
1699940379
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
4
Hospital affiliations
89 Lincoln Blvd
Lincoln, CA, 95648
Phone (916) 434-8800
Groups this clinician bills Medicare through
Medicare paid, 2024
$400K
5,228 services
Medicare patients, 2024
477
Average age 76
Drug cost, 2024
$748K
10,422 prescriptions
Company payments, 2025
$637
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ravi K Chinthakindi was code 99308 (snf e&m), 1,907 times for 266 patients. In total Ravi K Chinthakindi billed 5,228 services in 32 codes, and Medicare paid $400K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Facility | 1,907 | 266 | $59.18 | $113K |
| 99309 SNF E&M | Facility | 1,899 | 109 | $87.76 | $167K |
| 99214 Office E&M - Established | Office | 321 | 122 | $96.59 | $31K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 276 | 119 | $12.97 | $3,580 |
| 99306 SNF E&M | Facility | 254 | 192 | $146.23 | $37K |
| 99316 SNF E&M | Facility | 140 | 102 | $106.11 | $15K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 108 | 28 | $47.33 | $5,112 |
| 99310 SNF E&M | Facility | 70 | 25 | $123.61 | $8,653 |
| 99232 Hospital E&M - Subsequent | Facility | 62 | 15 | $63.20 | $3,918 |
| 99233 Hospital E&M - Subsequent | Facility | 37 | 11 | $95.12 | $3,519 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 28 | 28 | $136.64 | $3,826 |
| 99204 Office E&M - New | Office | 26 | 26 | $90.56 | $2,355 |
| 99315 SNF E&M | Facility | 20 | 20 | $66.81 | $1,336 |
| 81002 Clinical Chemistry | Office | 14 | 11 | $3.41 | $47.74 |
By year: 2022 $221K for 3,238 services; 2023 $327K for 3,934 services; 2024 $400K for 5,228 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 14 | 11 | $3.41 | $47.74 |
Medicare prescription drug claims, 2024
In 2024, the drug Ravi K Chinthakindi prescribed most often to Medicare patients was Atorvastatin Calcium, with 595 prescriptions and refills. In total Ravi K Chinthakindi wrote 10,422 Medicare prescriptions that cost $748K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 595 | 797 | 121 | $9,008 |
| Levothyroxine Sodium Generic | 423 | 599 | 70 | $4,746 |
| Amlodipine Besylate Generic | 283 | 369 | 57 | $3,065 |
| Eliquis Apixaban | 278 | 298 | 47 | $89K |
| Gabapentin Generic | 267 | 299 | 63 | $5,897 |
| Furosemide Generic | 255 | 285 | 60 | $1,870 |
| Metoprolol Tartrate Generic | 214 | 262 | 45 | $2,423 |
| Lisinopril Generic | 187 | 312 | 46 | $2,483 |
| Pantoprazole Sodium Generic | 174 | 216 | 52 | $5,922 |
| Tamsulosin Hcl Generic | 167 | 279 | 45 | $3,276 |
| Potassium Chloride Generic | 165 | 177 | 31 | $15K |
| Divalproex Sodium Generic | 152 | 162 | 27 | $6,153 |
| Trazodone Hcl Generic | 149 | 209 | 43 | $1,643 |
| Ondansetron Hcl Generic | 148 | 148 | 38 | $1,260 |
| Famotidine Generic | 144 | 162 | 32 | $3,224 |
Brand drugs: 1,883 claims; generic drugs: 8,509 claims; opioid claims: 406.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ravi K Chinthakindi $637 ($637 in general payments such as food, travel and fees) from 15 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $109.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $109 |
| Boston Scientific Corporation BSX | 3 | $81.67 |
| Exact Sciences Corporation EXAS | 2 | $61.43 |
| Pfizer Inc. PFE | 3 | $60.2 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $46.91 |
| Aimmune Therapeutics, Inc. | 2 | $46.69 |
| Lilly USA, LLC LLY | 2 | $45.34 |
| Cipher Pharmaceuticals US LLC CPH.TO | 1 | $31.38 |
| Amgen Inc. AMGN | 1 | $30.45 |
| UCB, Inc. UCB.BR | 1 | $29.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.